Position in MGNX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$488,730
+$229,497 QoQ
Shares Held
169,112
+5.0% QoQ
Ownership
0.266%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in MGNX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,440,401,210 across 521 Biotechnology names. MGNX ranks #287 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in MGNX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $488,730 | 169,112 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $259,233 | 161,016 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $1,661,908 | 989,233 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $539,925 | 446,222 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $433,682 | 341,485 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $3,589,382 | 1,104,426 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $1,052,366 | 319,869 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $2,007,003 | 472,237 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $3,119,870 | 211,948 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $3,378,299 | 351,175 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $1,646,266 | 353,277 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $2,374,085 | 443,755 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $4,613,561 | 643,454 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $4,342,855 | 647,222 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,696,538 | 779,348 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,998,469 | 677,449 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $5,401,530 | 613,114 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $3,947,736 | 245,965 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $740,099 | 35,344 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $5,562,219 | 207,082 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $654,165 | 20,539 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,287,015 | 56,300 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $934,269 | 37,089 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $977,532 | 35,012 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $152,267 | 26,163 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||